Primary uterine diffuse large B-cell lymphoma (DLBCL) in a patient with prolonged insertion of intrauterine device (IUD)
A 49-year-old female from China was referred to our hospital after endocervical polypectomy. Twenty years before admission, after the birth of her first child, an intrauterine device (IUD) had been inserted due to the one-child policy in China. She had noticed abnormal vaginal bleeding with a foul s...
Gespeichert in:
Veröffentlicht in: | International journal of hematology 2017-07, Vol.106 (1), p.138-140 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 140 |
---|---|
container_issue | 1 |
container_start_page | 138 |
container_title | International journal of hematology |
container_volume | 106 |
creator | Shimizu, Takuya Hatanaka, Kazuo Kaneko, Hitomi Shimada, Toshihide Imada, Kazunori |
description | A 49-year-old female from China was referred to our hospital after endocervical polypectomy. Twenty years before admission, after the birth of her first child, an intrauterine device (IUD) had been inserted due to the one-child policy in China. She had noticed abnormal vaginal bleeding with a foul smell 3 years before admission. Then the IUD was removed and a polyp was found at the IUD contact site. Two months before admission, endocervical polypectomy was performed. Lymphoma was suspected by histological examination and she was referred to our hospital. Further examination confirmed the diagnosis of primary uterine diffuse large B-cell lymphoma (DLBCL). Subsequently, a combination of three cycles of R-CHOP regimen and involved-field radiation therapy was performed, followed by maintenance therapy with five cycles of rituximab. She has remained in complete remission for over 1 year. This case suggests that chronic inflammation induced by prolonged IUD insertion may contribute to the development of primary uterine lymphoma. To the best of our knowledge, this is the first reported case of DLBCL associated with prolonged IUD insertion. |
doi_str_mv | 10.1007/s12185-017-2191-7 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1866291921</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1911523986</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-de33c1ff89f1bc96fb2854a0c5bc059f5adbee15fa1677cdf0e171c16db2d1493</originalsourceid><addsrcrecordid>eNp1kU1P3DAQhq2qVdnS_oBeKku9LAeDx1nH8RGWFpBWKodythxnDEb5WOyEj39frwKoQuI0suaZd8bvS8h34IfAuTpKIKCSjINiAjQw9YEsoColK5RafSQLroVkUgHfI19SuuUZ5Cv1meyJClQpRLUgj5cxdDY-0WnEGHqkTfB-SkhbG6-RnjCHbUvbp257M3SWLk83J-vNAQ09tXRrx4D9SB_CeEO3cWiH_hqb3EsYxzD0dPD5MUb7qo33wSFdXlydHnwln7xtE357rvvk6vevv-tztvlzdrE-3jBX6HJkDRaFA-8r7aF2uvS1qOTKcidrx6X20jY1IkhvoVTKNZ4jKHBQNrVoYKWLfbKcdfOBdxOm0XQh7T5lexymZLJfpdCgBWT05xv0dphin68z2V2QotBVmSmYKReHlCJ6s50tNMDNLhYzx2Ky22YXi1F55sez8lR32LxOvOSQATEDKbeyi_G_1e-q_gNVyJgO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1911523986</pqid></control><display><type>article</type><title>Primary uterine diffuse large B-cell lymphoma (DLBCL) in a patient with prolonged insertion of intrauterine device (IUD)</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Shimizu, Takuya ; Hatanaka, Kazuo ; Kaneko, Hitomi ; Shimada, Toshihide ; Imada, Kazunori</creator><creatorcontrib>Shimizu, Takuya ; Hatanaka, Kazuo ; Kaneko, Hitomi ; Shimada, Toshihide ; Imada, Kazunori</creatorcontrib><description>A 49-year-old female from China was referred to our hospital after endocervical polypectomy. Twenty years before admission, after the birth of her first child, an intrauterine device (IUD) had been inserted due to the one-child policy in China. She had noticed abnormal vaginal bleeding with a foul smell 3 years before admission. Then the IUD was removed and a polyp was found at the IUD contact site. Two months before admission, endocervical polypectomy was performed. Lymphoma was suspected by histological examination and she was referred to our hospital. Further examination confirmed the diagnosis of primary uterine diffuse large B-cell lymphoma (DLBCL). Subsequently, a combination of three cycles of R-CHOP regimen and involved-field radiation therapy was performed, followed by maintenance therapy with five cycles of rituximab. She has remained in complete remission for over 1 year. This case suggests that chronic inflammation induced by prolonged IUD insertion may contribute to the development of primary uterine lymphoma. To the best of our knowledge, this is the first reported case of DLBCL associated with prolonged IUD insertion.</description><identifier>ISSN: 0925-5710</identifier><identifier>EISSN: 1865-3774</identifier><identifier>DOI: 10.1007/s12185-017-2191-7</identifier><identifier>PMID: 28176228</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>B-cell lymphoma ; Biopsy ; Bleeding ; Case Report ; Combined Modality Therapy ; Female ; Hematology ; Humans ; Immunohistochemistry ; Insertion ; Intrauterine devices ; Intrauterine Devices - adverse effects ; IUD ; Lymphocytes B ; Lymphoma ; Lymphoma, Large B-Cell, Diffuse - diagnosis ; Lymphoma, Large B-Cell, Diffuse - etiology ; Lymphoma, Large B-Cell, Diffuse - therapy ; Magnetic Resonance Imaging - methods ; Medicine ; Medicine & Public Health ; Middle Aged ; Monoclonal antibodies ; Oncology ; Polyps ; Radiation ; Radiation therapy ; Remission ; Rituximab ; Smell ; Targeted cancer therapy ; Treatment Outcome ; Uterine Neoplasms - diagnosis ; Uterine Neoplasms - etiology ; Uterine Neoplasms - therapy ; Uterus ; Vagina</subject><ispartof>International journal of hematology, 2017-07, Vol.106 (1), p.138-140</ispartof><rights>The Japanese Society of Hematology 2017</rights><rights>International Journal of Hematology is a copyright of Springer, 2017.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-de33c1ff89f1bc96fb2854a0c5bc059f5adbee15fa1677cdf0e171c16db2d1493</citedby><cites>FETCH-LOGICAL-c396t-de33c1ff89f1bc96fb2854a0c5bc059f5adbee15fa1677cdf0e171c16db2d1493</cites><orcidid>0000-0002-0945-0513</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12185-017-2191-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12185-017-2191-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28176228$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shimizu, Takuya</creatorcontrib><creatorcontrib>Hatanaka, Kazuo</creatorcontrib><creatorcontrib>Kaneko, Hitomi</creatorcontrib><creatorcontrib>Shimada, Toshihide</creatorcontrib><creatorcontrib>Imada, Kazunori</creatorcontrib><title>Primary uterine diffuse large B-cell lymphoma (DLBCL) in a patient with prolonged insertion of intrauterine device (IUD)</title><title>International journal of hematology</title><addtitle>Int J Hematol</addtitle><addtitle>Int J Hematol</addtitle><description>A 49-year-old female from China was referred to our hospital after endocervical polypectomy. Twenty years before admission, after the birth of her first child, an intrauterine device (IUD) had been inserted due to the one-child policy in China. She had noticed abnormal vaginal bleeding with a foul smell 3 years before admission. Then the IUD was removed and a polyp was found at the IUD contact site. Two months before admission, endocervical polypectomy was performed. Lymphoma was suspected by histological examination and she was referred to our hospital. Further examination confirmed the diagnosis of primary uterine diffuse large B-cell lymphoma (DLBCL). Subsequently, a combination of three cycles of R-CHOP regimen and involved-field radiation therapy was performed, followed by maintenance therapy with five cycles of rituximab. She has remained in complete remission for over 1 year. This case suggests that chronic inflammation induced by prolonged IUD insertion may contribute to the development of primary uterine lymphoma. To the best of our knowledge, this is the first reported case of DLBCL associated with prolonged IUD insertion.</description><subject>B-cell lymphoma</subject><subject>Biopsy</subject><subject>Bleeding</subject><subject>Case Report</subject><subject>Combined Modality Therapy</subject><subject>Female</subject><subject>Hematology</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Insertion</subject><subject>Intrauterine devices</subject><subject>Intrauterine Devices - adverse effects</subject><subject>IUD</subject><subject>Lymphocytes B</subject><subject>Lymphoma</subject><subject>Lymphoma, Large B-Cell, Diffuse - diagnosis</subject><subject>Lymphoma, Large B-Cell, Diffuse - etiology</subject><subject>Lymphoma, Large B-Cell, Diffuse - therapy</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Monoclonal antibodies</subject><subject>Oncology</subject><subject>Polyps</subject><subject>Radiation</subject><subject>Radiation therapy</subject><subject>Remission</subject><subject>Rituximab</subject><subject>Smell</subject><subject>Targeted cancer therapy</subject><subject>Treatment Outcome</subject><subject>Uterine Neoplasms - diagnosis</subject><subject>Uterine Neoplasms - etiology</subject><subject>Uterine Neoplasms - therapy</subject><subject>Uterus</subject><subject>Vagina</subject><issn>0925-5710</issn><issn>1865-3774</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kU1P3DAQhq2qVdnS_oBeKku9LAeDx1nH8RGWFpBWKodythxnDEb5WOyEj39frwKoQuI0suaZd8bvS8h34IfAuTpKIKCSjINiAjQw9YEsoColK5RafSQLroVkUgHfI19SuuUZ5Cv1meyJClQpRLUgj5cxdDY-0WnEGHqkTfB-SkhbG6-RnjCHbUvbp257M3SWLk83J-vNAQ09tXRrx4D9SB_CeEO3cWiH_hqb3EsYxzD0dPD5MUb7qo33wSFdXlydHnwln7xtE357rvvk6vevv-tztvlzdrE-3jBX6HJkDRaFA-8r7aF2uvS1qOTKcidrx6X20jY1IkhvoVTKNZ4jKHBQNrVoYKWLfbKcdfOBdxOm0XQh7T5lexymZLJfpdCgBWT05xv0dphin68z2V2QotBVmSmYKReHlCJ6s50tNMDNLhYzx2Ky22YXi1F55sez8lR32LxOvOSQATEDKbeyi_G_1e-q_gNVyJgO</recordid><startdate>20170701</startdate><enddate>20170701</enddate><creator>Shimizu, Takuya</creator><creator>Hatanaka, Kazuo</creator><creator>Kaneko, Hitomi</creator><creator>Shimada, Toshihide</creator><creator>Imada, Kazunori</creator><general>Springer Japan</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0945-0513</orcidid></search><sort><creationdate>20170701</creationdate><title>Primary uterine diffuse large B-cell lymphoma (DLBCL) in a patient with prolonged insertion of intrauterine device (IUD)</title><author>Shimizu, Takuya ; Hatanaka, Kazuo ; Kaneko, Hitomi ; Shimada, Toshihide ; Imada, Kazunori</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-de33c1ff89f1bc96fb2854a0c5bc059f5adbee15fa1677cdf0e171c16db2d1493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>B-cell lymphoma</topic><topic>Biopsy</topic><topic>Bleeding</topic><topic>Case Report</topic><topic>Combined Modality Therapy</topic><topic>Female</topic><topic>Hematology</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Insertion</topic><topic>Intrauterine devices</topic><topic>Intrauterine Devices - adverse effects</topic><topic>IUD</topic><topic>Lymphocytes B</topic><topic>Lymphoma</topic><topic>Lymphoma, Large B-Cell, Diffuse - diagnosis</topic><topic>Lymphoma, Large B-Cell, Diffuse - etiology</topic><topic>Lymphoma, Large B-Cell, Diffuse - therapy</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Monoclonal antibodies</topic><topic>Oncology</topic><topic>Polyps</topic><topic>Radiation</topic><topic>Radiation therapy</topic><topic>Remission</topic><topic>Rituximab</topic><topic>Smell</topic><topic>Targeted cancer therapy</topic><topic>Treatment Outcome</topic><topic>Uterine Neoplasms - diagnosis</topic><topic>Uterine Neoplasms - etiology</topic><topic>Uterine Neoplasms - therapy</topic><topic>Uterus</topic><topic>Vagina</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shimizu, Takuya</creatorcontrib><creatorcontrib>Hatanaka, Kazuo</creatorcontrib><creatorcontrib>Kaneko, Hitomi</creatorcontrib><creatorcontrib>Shimada, Toshihide</creatorcontrib><creatorcontrib>Imada, Kazunori</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shimizu, Takuya</au><au>Hatanaka, Kazuo</au><au>Kaneko, Hitomi</au><au>Shimada, Toshihide</au><au>Imada, Kazunori</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Primary uterine diffuse large B-cell lymphoma (DLBCL) in a patient with prolonged insertion of intrauterine device (IUD)</atitle><jtitle>International journal of hematology</jtitle><stitle>Int J Hematol</stitle><addtitle>Int J Hematol</addtitle><date>2017-07-01</date><risdate>2017</risdate><volume>106</volume><issue>1</issue><spage>138</spage><epage>140</epage><pages>138-140</pages><issn>0925-5710</issn><eissn>1865-3774</eissn><abstract>A 49-year-old female from China was referred to our hospital after endocervical polypectomy. Twenty years before admission, after the birth of her first child, an intrauterine device (IUD) had been inserted due to the one-child policy in China. She had noticed abnormal vaginal bleeding with a foul smell 3 years before admission. Then the IUD was removed and a polyp was found at the IUD contact site. Two months before admission, endocervical polypectomy was performed. Lymphoma was suspected by histological examination and she was referred to our hospital. Further examination confirmed the diagnosis of primary uterine diffuse large B-cell lymphoma (DLBCL). Subsequently, a combination of three cycles of R-CHOP regimen and involved-field radiation therapy was performed, followed by maintenance therapy with five cycles of rituximab. She has remained in complete remission for over 1 year. This case suggests that chronic inflammation induced by prolonged IUD insertion may contribute to the development of primary uterine lymphoma. To the best of our knowledge, this is the first reported case of DLBCL associated with prolonged IUD insertion.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>28176228</pmid><doi>10.1007/s12185-017-2191-7</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-0945-0513</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0925-5710 |
ispartof | International journal of hematology, 2017-07, Vol.106 (1), p.138-140 |
issn | 0925-5710 1865-3774 |
language | eng |
recordid | cdi_proquest_miscellaneous_1866291921 |
source | MEDLINE; SpringerLink Journals |
subjects | B-cell lymphoma Biopsy Bleeding Case Report Combined Modality Therapy Female Hematology Humans Immunohistochemistry Insertion Intrauterine devices Intrauterine Devices - adverse effects IUD Lymphocytes B Lymphoma Lymphoma, Large B-Cell, Diffuse - diagnosis Lymphoma, Large B-Cell, Diffuse - etiology Lymphoma, Large B-Cell, Diffuse - therapy Magnetic Resonance Imaging - methods Medicine Medicine & Public Health Middle Aged Monoclonal antibodies Oncology Polyps Radiation Radiation therapy Remission Rituximab Smell Targeted cancer therapy Treatment Outcome Uterine Neoplasms - diagnosis Uterine Neoplasms - etiology Uterine Neoplasms - therapy Uterus Vagina |
title | Primary uterine diffuse large B-cell lymphoma (DLBCL) in a patient with prolonged insertion of intrauterine device (IUD) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T15%3A00%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Primary%20uterine%20diffuse%20large%20B-cell%20lymphoma%20(DLBCL)%20in%20a%20patient%20with%20prolonged%20insertion%20of%20intrauterine%20device%20(IUD)&rft.jtitle=International%20journal%20of%20hematology&rft.au=Shimizu,%20Takuya&rft.date=2017-07-01&rft.volume=106&rft.issue=1&rft.spage=138&rft.epage=140&rft.pages=138-140&rft.issn=0925-5710&rft.eissn=1865-3774&rft_id=info:doi/10.1007/s12185-017-2191-7&rft_dat=%3Cproquest_cross%3E1911523986%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1911523986&rft_id=info:pmid/28176228&rfr_iscdi=true |